Pub Date : 2026-02-01Epub Date: 2026-02-24DOI: 10.1177/03913988261422333
Mustafa Selcuk Atasoy, Hakan Guven, Ahmet Yuksel, Demir Cetintas, Gencehan Kumtepe, Yusuf Velioglu
Introduction: We aimed to investigate the impact of preoperative Arterial Stiffness Index (ASI) values on primary graft patency following peripheral arterial bypass surgery.
Methods: This retrospective cohort study included 92 patients who underwent femoro-popliteal bypass surgery between January 2019 and November 2024. Preoperative ASI values were measured using the Vasolab 5000 device. Patients were divided into two groups based on an ASI cut-off value of 10.0. Primary graft patency rates, Kaplan-Meier survival analysis, and multivariate Cox regression were performed to assess the relationship between ASI and graft outcomes.
Results: Patients with ASI >10.0 exhibited significantly lower 12-month primary graft patency rates compared to those with ASI ⩽10.0 (61.9% vs 88.0%, p = 0.008). Multivariate Cox regression analysis identified high ASI as an independent predictor of graft failure (HR: 2.15; 95% CI: 1.15-4.03; p = 0.016), along with diabetes mellitus and the use of synthetic graft material.
Conclusion: Preoperative ASI values are independently associated with primary graft patency after peripheral arterial bypass surgery. Arterial stiffness assessment may serve as a useful non-invasive tool for risk stratification in vascular surgery candidates.
前言:我们的目的是研究术前动脉硬度指数(ASI)值对周围动脉搭桥手术后移植物初级通畅的影响。方法:本回顾性队列研究纳入了2019年1月至2024年11月期间接受股腘动脉搭桥手术的92例患者。术前ASI值使用Vasolab 5000设备测量。根据ASI分值10.0将患者分为两组。通过一期移植物通畅率、Kaplan-Meier生存分析和多变量Cox回归来评估ASI与移植物结局之间的关系。结果:与ASI≥10.0的患者相比,ASI≥10.0的患者12个月一期移植物通畅率显著降低(61.9% vs 88.0%, p = 0.008)。多因素Cox回归分析发现,高ASI是移植物失败的独立预测因子(HR: 2.15; 95% CI: 1.15-4.03; p = 0.016),以及糖尿病和使用合成移植物材料。结论:术前ASI值与外周动脉搭桥术后移植物一期通畅独立相关。动脉硬度评估可作为血管外科候选人危险分层的有用的非侵入性工具。
{"title":"Impact of preoperative arterial stiffness index on graft patency following peripheral arterial bypass surgery.","authors":"Mustafa Selcuk Atasoy, Hakan Guven, Ahmet Yuksel, Demir Cetintas, Gencehan Kumtepe, Yusuf Velioglu","doi":"10.1177/03913988261422333","DOIUrl":"10.1177/03913988261422333","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to investigate the impact of preoperative Arterial Stiffness Index (ASI) values on primary graft patency following peripheral arterial bypass surgery.</p><p><strong>Methods: </strong>This retrospective cohort study included 92 patients who underwent femoro-popliteal bypass surgery between January 2019 and November 2024. Preoperative ASI values were measured using the Vasolab 5000 device. Patients were divided into two groups based on an ASI cut-off value of 10.0. Primary graft patency rates, Kaplan-Meier survival analysis, and multivariate Cox regression were performed to assess the relationship between ASI and graft outcomes.</p><p><strong>Results: </strong>Patients with ASI >10.0 exhibited significantly lower 12-month primary graft patency rates compared to those with ASI ⩽10.0 (61.9% vs 88.0%, <i>p</i> = 0.008). Multivariate Cox regression analysis identified high ASI as an independent predictor of graft failure (HR: 2.15; 95% CI: 1.15-4.03; <i>p</i> = 0.016), along with diabetes mellitus and the use of synthetic graft material.</p><p><strong>Conclusion: </strong>Preoperative ASI values are independently associated with primary graft patency after peripheral arterial bypass surgery. Arterial stiffness assessment may serve as a useful non-invasive tool for risk stratification in vascular surgery candidates.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"100-107"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-01-21DOI: 10.1177/03913988251412192
Fatma Büşra Çakır Kunt, Fatih Ergül, Çağdaş Kunt, Fatih Saçkan, İbrahim Güney, Muhammet Cemal Kızılarslanoğlu
Background: This study aimed to evaluate the impact of sarcopenia and frailty on the quality of life of older hemodialysis patients.
Methods: Seventy hemodialysis patients aged ⩾60 years were assessed. Daily living activities (Katz Index), depression (Yesavage Scale), frailty (Fried's Criteria), and sarcopenia (EWGSOP2) were evaluated. Quality of life was measured using the KDQOL-36 questionnaire.
Results: The median age was 67 years, and 50% were female. Nineteen patients (27.1%) were partially dependent, 71.4% were pre-frail, and 15.7% were frail. Probable sarcopenia was detected in 77.1%, and sarcopenia in 8.6% of patients. Sarcopenia was associated with older age, higher dependency, depression, lower income, and frailty (p < 0.05). It was also related to the KDQOL-36 physical component (p = 0.031), while frailty correlated with the symptom component (p = 0.047).
Conclusion: Frailty and sarcopenia are common in older hemodialysis patients and adversely affect their quality of life.
背景:本研究旨在评估骨骼肌减少症和虚弱对老年血液透析患者生活质量的影响。方法:评估70名年龄大于或等于60岁的血液透析患者。对日常生活活动(Katz指数)、抑郁(Yesavage量表)、虚弱(Fried标准)和肌肉减少症(EWGSOP2)进行评估。生活质量采用KDQOL-36问卷进行测量。结果:中位年龄67岁,女性占50%。部分依赖19例(27.1%),体弱前期71.4%,体弱期15.7%。77.1%的患者检出可能的肌肉减少症,8.6%的患者检出肌肉减少症。骨骼肌减少症与年龄较大、依赖性较高、抑郁、收入较低和虚弱相关(p p = 0.031),而虚弱与症状相关(p = 0.047)。结论:老年血透患者体弱多病和肌肉减少症普遍存在,并对其生活质量产生不良影响。
{"title":"Evaluation of the effect of sarcopenia and frailty on quality of life in older hemodialysis patients.","authors":"Fatma Büşra Çakır Kunt, Fatih Ergül, Çağdaş Kunt, Fatih Saçkan, İbrahim Güney, Muhammet Cemal Kızılarslanoğlu","doi":"10.1177/03913988251412192","DOIUrl":"10.1177/03913988251412192","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the impact of sarcopenia and frailty on the quality of life of older hemodialysis patients.</p><p><strong>Methods: </strong>Seventy hemodialysis patients aged ⩾60 years were assessed. Daily living activities (Katz Index), depression (Yesavage Scale), frailty (Fried's Criteria), and sarcopenia (EWGSOP2) were evaluated. Quality of life was measured using the KDQOL-36 questionnaire.</p><p><strong>Results: </strong>The median age was 67 years, and 50% were female. Nineteen patients (27.1%) were partially dependent, 71.4% were pre-frail, and 15.7% were frail. Probable sarcopenia was detected in 77.1%, and sarcopenia in 8.6% of patients. Sarcopenia was associated with older age, higher dependency, depression, lower income, and frailty (<i>p</i> < 0.05). It was also related to the KDQOL-36 physical component (<i>p</i> = 0.031), while frailty correlated with the symptom component (<i>p</i> = 0.047).</p><p><strong>Conclusion: </strong>Frailty and sarcopenia are common in older hemodialysis patients and adversely affect their quality of life.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"126-132"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146009871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2026-02-08DOI: 10.1177/03913988251415094
Alexander Novokhodko, Nanye Du, Shaohang Hao, Ziyuan Wang, Martin Sadilek, Zhiquan Shu, Suhail Ahmad, Dayong Gao
Cholic acid (CA) and indoxyl sulfate (IS) are toxins associated with biliary and renal disease. Protein binding prevents removal by traditional dialysis. Dissolving binding molecules such as albumin in dialysate enables detoxification. We created a benchtop albumin dialysis test platform. We used it to validate a mathematical model of CA/IS removal. Toxin-containing blood analog solution was dialyzed using two dialyzers at five flow rates against albumin dialysate. One condition was used to estimate toxin binding affinity to albumin and the free toxin transmembrane transfer coefficient (KfreeA). Other conditions validated modeling results and revealed the impact of dialysate flow rate and dialyzer properties on detoxification (measured by mass spectrometry). We accurately predicted CA/IS removal. The normalized root mean squared error never exceeds 11.5% of the starting amount. Increasing dialysate side flow rate up to 150 mL/min improved toxin removal. Further increases produced no benefit. KfreeA was independent of flow rate. Our data fits a result from the newly developed AMOR system, in which total bile acids declined with treatment. This model and benchtop setup aim to predict clinical CA/IS clearance and optimize device design for clinical trials. This will mean fewer unsuccessful trials and enable testing of new dialysate formulations.
{"title":"Albumin dialysis modeling predicts the impact of polysulfone dialyzers and flow rate on cholic acid and indoxyl sulfate removal.","authors":"Alexander Novokhodko, Nanye Du, Shaohang Hao, Ziyuan Wang, Martin Sadilek, Zhiquan Shu, Suhail Ahmad, Dayong Gao","doi":"10.1177/03913988251415094","DOIUrl":"10.1177/03913988251415094","url":null,"abstract":"<p><p>Cholic acid (CA) and indoxyl sulfate (IS) are toxins associated with biliary and renal disease. Protein binding prevents removal by traditional dialysis. Dissolving binding molecules such as albumin in dialysate enables detoxification. We created a benchtop albumin dialysis test platform. We used it to validate a mathematical model of CA/IS removal. Toxin-containing blood analog solution was dialyzed using two dialyzers at five flow rates against albumin dialysate. One condition was used to estimate toxin binding affinity to albumin and the free toxin transmembrane transfer coefficient (K<sub>free</sub>A). Other conditions validated modeling results and revealed the impact of dialysate flow rate and dialyzer properties on detoxification (measured by mass spectrometry). We accurately predicted CA/IS removal. The normalized root mean squared error never exceeds 11.5% of the starting amount. Increasing dialysate side flow rate up to 150 mL/min improved toxin removal. Further increases produced no benefit. K<sub>free</sub>A was independent of flow rate. Our data fits a result from the newly developed AMOR system, in which total bile acids declined with treatment. This model and benchtop setup aim to predict clinical CA/IS clearance and optimize device design for clinical trials. This will mean fewer unsuccessful trials and enable testing of new dialysate formulations.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"115-125"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This case describes an 82-year-old male patient presenting with persistent upper abdominal colic, diagnosed as severe acute pancreatitis. The patient then suffered a cytokine storm, as well as renal dysfunction. Therefore, the patient underwent two sessions of coupled plasma filtration adsorption (CPFA) therapy utilising the CA330 cytokine adsorption cartridge as the adsorbent. The first CPFA session lasted 8 h, followed by a 4-h interval (during which continuous veno-venous haemodialysis therapy was provided), and the second 8-h CPFA session started. Due to family requests and comprehensive consideration by the medical team, the second CPFA session was extended to 20 h. Ultimately, the patient was weaned off blood purification therapy (43 h after its initiation). The study demonstrated a significant reduction in cytokine levels as the course of treatment increased. However, beyond a specific threshold, cytokine adsorption may reach saturation. The medicinal applications of CPFA (particularly CA330) deserve more investigation.
{"title":"Application of the CA330 cytokine adsorption cartridge for coupled plasma filtration adsorption therapy in severe acute pancreatitis-induced cytokine storm: A case report.","authors":"Xiankun Sun, Fang Wang, Li Lin, Xue Tang, Zhiwen Chen, Ling Zhang","doi":"10.1177/03913988261422649","DOIUrl":"10.1177/03913988261422649","url":null,"abstract":"<p><p>This case describes an 82-year-old male patient presenting with persistent upper abdominal colic, diagnosed as severe acute pancreatitis. The patient then suffered a cytokine storm, as well as renal dysfunction. Therefore, the patient underwent two sessions of coupled plasma filtration adsorption (CPFA) therapy utilising the CA330 cytokine adsorption cartridge as the adsorbent. The first CPFA session lasted 8 h, followed by a 4-h interval (during which continuous veno-venous haemodialysis therapy was provided), and the second 8-h CPFA session started. Due to family requests and comprehensive consideration by the medical team, the second CPFA session was extended to 20 h. Ultimately, the patient was weaned off blood purification therapy (43 h after its initiation). The study demonstrated a significant reduction in cytokine levels as the course of treatment increased. However, beyond a specific threshold, cytokine adsorption may reach saturation. The medicinal applications of CPFA (particularly CA330) deserve more investigation.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"108-114"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Perforation on tympanic membrane could decrease the hearing ability. In some cases, myringoplasty should be performed. Myringoplasty requires material as patch to cover tympanic membrane's hole. This study is aimed to create innovation based on chitosan-collagen with glycerol plasticizers as scaffold patch for tympanic membrane perforation. The sample preparation method included mixing various concentrations of chitosan-collagen with the ratio of 1:0; 9:1; 8:2; 7:3 and 0.5 ml of glycerol for each sample variation. The characterization included FTIR test, morphological test, sound transmission class test, tensile strength test, degradation test, swelling test, and antibacterial test. The functional group test showed that in the sample variations 9:1; 8:2; 7:3 there was an absorption at the wave number 2347 cm-1 which showed deformation of the NH group. Morphological analysis showed that as the collagen concentration increased, the microstructure exhibited more pronounced fine wrinkles. The sound transmission class test showed all sample variations did not reduce the sound so the scaffold patch transmitted sound properly. Tensile strength test showed the sample with the variation of 8:2 had the greatest strength value (8.02 MPa) but still below the value of tympanic membrane tensile strength ±20 MPa. The degradation test showed the samples were able to survive during the tympanic membrane healing process for approximately one until 2 months. The optimization of plasticizer amount need to be adjusted in order to increase tensile strength. The presence of free hydrophilic groups (group COOH, NH2, and -OH) cause the sample to have hydrophilic properties so that it is easily degraded and undergoes swelling. In antibacterial assay, the inhibition zone was not formed because chitosan could not diffuse through the agar.
{"title":"Biodegradable patch based on chitosan-collagen with glycerol plasticizer as scaffold for tympanic membrane perforation.","authors":"Prihartini Widiyanti, Arkan Fahrian Putra, Djony Izak Rudyardjo","doi":"10.1177/03913988251412204","DOIUrl":"10.1177/03913988251412204","url":null,"abstract":"<p><p>Perforation on tympanic membrane could decrease the hearing ability. In some cases, myringoplasty should be performed. Myringoplasty requires material as patch to cover tympanic membrane's hole. This study is aimed to create innovation based on chitosan-collagen with glycerol plasticizers as scaffold patch for tympanic membrane perforation. The sample preparation method included mixing various concentrations of chitosan-collagen with the ratio of 1:0; 9:1; 8:2; 7:3 and 0.5 ml of glycerol for each sample variation. The characterization included FTIR test, morphological test, sound transmission class test, tensile strength test, degradation test, swelling test, and antibacterial test. The functional group test showed that in the sample variations 9:1; 8:2; 7:3 there was an absorption at the wave number 2347 cm<sup>-1</sup> which showed deformation of the NH group. Morphological analysis showed that as the collagen concentration increased, the microstructure exhibited more pronounced fine wrinkles. The sound transmission class test showed all sample variations did not reduce the sound so the scaffold patch transmitted sound properly. Tensile strength test showed the sample with the variation of 8:2 had the greatest strength value (8.02 MPa) but still below the value of tympanic membrane tensile strength ±20 MPa. The degradation test showed the samples were able to survive during the tympanic membrane healing process for approximately one until 2 months. The optimization of plasticizer amount need to be adjusted in order to increase tensile strength. The presence of free hydrophilic groups (group COOH, NH2, and -OH) cause the sample to have hydrophilic properties so that it is easily degraded and undergoes swelling. In antibacterial assay, the inhibition zone was not formed because chitosan could not diffuse through the agar.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"133-140"},"PeriodicalIF":1.3,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: This study aimed to assess the relationship between arteriovenous fistula (AVF) functional status and quality of life and to identify influencing factors.
Method: Data for this cross-sectional study were collected from 221 chronic hemodialysis patients between May and September 2024.
Results: AVF functional status was significantly lower in male patients who had undergone four or more AVF operations, had an AVF at the elbow site, or had two to three temporary catheter insertions. There was a moderate negative correlation between the SF-12 Physical Composite and age and a positive correlation between Kt/V. There was a moderate negative correlation between the SF-12 Physical Composite and AVF-AS. The regression analysis revealed that the blood pump speed, Kt/V, and the SF-12 Physical Composite significantly affected the AVF-AS scores, explaining 21.5% of the total variance.
Conclusion: In our study, we founded that a well-functioning AVF provided adequate dialysis, improving the patients' physical quality of life.
{"title":"Functional status of arteriovenous fistula and quality of life in hemodialysis patients.","authors":"Elif Bulbul, Elçin Sebahat Kasapoğlu, Meryem Yildiz Ayvaz","doi":"10.1177/03913988251398849","DOIUrl":"10.1177/03913988251398849","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to assess the relationship between arteriovenous fistula (AVF) functional status and quality of life and to identify influencing factors.</p><p><strong>Method: </strong>Data for this cross-sectional study were collected from 221 chronic hemodialysis patients between May and September 2024.</p><p><strong>Results: </strong>AVF functional status was significantly lower in male patients who had undergone four or more AVF operations, had an AVF at the elbow site, or had two to three temporary catheter insertions. There was a moderate negative correlation between the SF-12 Physical Composite and age and a positive correlation between <i>Kt</i>/<i>V</i>. There was a moderate negative correlation between the SF-12 Physical Composite and AVF-AS. The regression analysis revealed that the blood pump speed, <i>Kt</i>/<i>V</i>, and the SF-12 Physical Composite significantly affected the AVF-AS scores, explaining 21.5% of the total variance.</p><p><strong>Conclusion: </strong>In our study, we founded that a well-functioning AVF provided adequate dialysis, improving the patients' physical quality of life.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"11-16"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-17DOI: 10.1177/03913988251401780
Zheqin Yu, Jin Liu, Jianping Tan, Zhiyong Xiao, Yuanying Du
Blood-handling devices are commonly used for blood transportation or regulation, but their specialized flow channel geometries tend to create high-shear-stress flow regimes, which may induce excessive cellular damage risks and energy dissipation. To address this, this study combines computational fluid dynamics and particle image velocimetry experimental methods to establish nozzle reference models with multiple orifice diameter configurations. Based on entropy generation theory and Ω vortex identification methods, the underlying energy dissipation mechanisms and vortex dynamics under distinct high-shear-stress conditions are analyzed. The results indicate that shear flow intensity is highly correlated with energy dissipation due to entropy production. Attenuating turbulence in the flow field simultaneously suppresses shear stress damage and energy loss, while lowering shear flow intensity promotes the decomposition of vortices downstream, broadening their spatial distribution. High flow velocity alone does not directly induce shear stress or entropy-related energy dissipation; rather, an excessively steep velocity gradient is the primary factor affecting flow field safety and efficiency. A 94% rise in velocity gradient results in average increases of 97.6% in shear stress and 99.6% in energy entropy production. During flow regime transition or under pronounced velocity gradients, shear-dominated vortices readily form and generate vortex-like energy dissipation during evolution, which is a key factor exacerbating energy loss in high-shear-stress flow fields. This study elucidates the energy dissipation mechanisms and vortex dynamics in high-shear-stress flow fields of blood-handling devices, providing theoretical and technical support for optimizing flow fields and performance in relevant devices.
{"title":"Investigation of vortex characteristics and energy dissipation mechanisms in the high-shear-stress flow fields of blood-handling devices.","authors":"Zheqin Yu, Jin Liu, Jianping Tan, Zhiyong Xiao, Yuanying Du","doi":"10.1177/03913988251401780","DOIUrl":"10.1177/03913988251401780","url":null,"abstract":"<p><p>Blood-handling devices are commonly used for blood transportation or regulation, but their specialized flow channel geometries tend to create high-shear-stress flow regimes, which may induce excessive cellular damage risks and energy dissipation. To address this, this study combines computational fluid dynamics and particle image velocimetry experimental methods to establish nozzle reference models with multiple orifice diameter configurations. Based on entropy generation theory and Ω vortex identification methods, the underlying energy dissipation mechanisms and vortex dynamics under distinct high-shear-stress conditions are analyzed. The results indicate that shear flow intensity is highly correlated with energy dissipation due to entropy production. Attenuating turbulence in the flow field simultaneously suppresses shear stress damage and energy loss, while lowering shear flow intensity promotes the decomposition of vortices downstream, broadening their spatial distribution. High flow velocity alone does not directly induce shear stress or entropy-related energy dissipation; rather, an excessively steep velocity gradient is the primary factor affecting flow field safety and efficiency. A 94% rise in velocity gradient results in average increases of 97.6% in shear stress and 99.6% in energy entropy production. During flow regime transition or under pronounced velocity gradients, shear-dominated vortices readily form and generate vortex-like energy dissipation during evolution, which is a key factor exacerbating energy loss in high-shear-stress flow fields. This study elucidates the energy dissipation mechanisms and vortex dynamics in high-shear-stress flow fields of blood-handling devices, providing theoretical and technical support for optimizing flow fields and performance in relevant devices.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"62-82"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145767964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2026-01-05DOI: 10.1177/03913988251403838
Elif Bulbul, Selda Çelik, Aysun Ünal, Üstün Yilmaz, Tuğba Çepken
Aim: Patients with ESRD who receive dialysis experience a wide range of unpleasant symptoms that have a negative effect on patient prognosis. The aim of this study was to evaluate the relationship between dialysis symptoms, adherence to interdialytic weight gain, fluid control, and associated factors in hemodialysis patients.
Methods: This study was conducted in a descriptive and cross-sectional design. Demographic and clinical characteristics form, mean of interdialytic weight gain last 12 hemodialysis sessions, Fluid Control in Hemodialysis Patients Scale, and Dialysis Symptom Index (DSI) were used to collect data.
Results: Patients with chronic illnesses and unemployment patients experienced higher DSI scores. The literate participants had a significantly higher DSI and lower adequacy of fluid intake. The regression analysis results showed that employment, chronic diseases, dialysis adequacy, and compliance with fluid intake explained 20.3% of the variance and that the model was a significant predictor of the DSI.
Conclusion: Dialysis symptoms were seen prevalently among the patients, and factors such as employment status, chronic disease, dialysis adequacy, and fluid intake compliance affected the DSI. It is important to monitor the fluid volume status and hemodialysis symptoms of hemodialysis patients regularly.
{"title":"Dialysis symptoms, fluid compliance, and related factors in hemodialysis patients.","authors":"Elif Bulbul, Selda Çelik, Aysun Ünal, Üstün Yilmaz, Tuğba Çepken","doi":"10.1177/03913988251403838","DOIUrl":"10.1177/03913988251403838","url":null,"abstract":"<p><strong>Aim: </strong>Patients with ESRD who receive dialysis experience a wide range of unpleasant symptoms that have a negative effect on patient prognosis. The aim of this study was to evaluate the relationship between dialysis symptoms, adherence to interdialytic weight gain, fluid control, and associated factors in hemodialysis patients.</p><p><strong>Methods: </strong>This study was conducted in a descriptive and cross-sectional design. Demographic and clinical characteristics form, mean of interdialytic weight gain last 12 hemodialysis sessions, Fluid Control in Hemodialysis Patients Scale, and Dialysis Symptom Index (DSI) were used to collect data.</p><p><strong>Results: </strong>Patients with chronic illnesses and unemployment patients experienced higher DSI scores. The literate participants had a significantly higher DSI and lower adequacy of fluid intake. The regression analysis results showed that employment, chronic diseases, dialysis adequacy, and compliance with fluid intake explained 20.3% of the variance and that the model was a significant predictor of the DSI.</p><p><strong>Conclusion: </strong>Dialysis symptoms were seen prevalently among the patients, and factors such as employment status, chronic disease, dialysis adequacy, and fluid intake compliance affected the DSI. It is important to monitor the fluid volume status and hemodialysis symptoms of hemodialysis patients regularly.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"3-10"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Refractory septic shock (RSS) in children carries high mortality despite advances in critical care. Extracorporeal membrane oxygenation (ECMO) is a rescue therapy when conventional management fails. Evidence from Latin America remains limited, with no detailed reports from Chile.
Methods: We conducted a retrospective single-center study (2009-2024) in a Chilean Pediatric ICU. Patients aged 1 month to 17 years with septic shock unresponsive to maximal conventional therapy were included. We analyzed demographics, illness severity, ECMO modality, complications, and outcomes. Primary endpoint was survival to hospital discharge.
Results: Nine patients received ECMO (median age = 6.3 years). All had RSS, frequently associated with severe ARDS. Configurations included venoarterial (VA; n = 4), venovenous (VV; n = 4), and venoarteriovenous (VAV; n = 1), all via peripheral cannulation. Pre-ECMO median vasoactive-inotropic score was 117, and 78% required renal replacement therapy during ECMO. Overall survival was 55% (5/9). Survivors had longer ECMO runs (median 11 days vs 3 days) and ICU stays (median 63 days vs 5 days). Hemorrhage was the most frequent complication (intracranial n = 3; gastrointestinal n = 1). One survivor developed hemiparesis; no cognitive impairment was observed at 1-year follow-up.
Conclusions: ECMO can be an effective rescue therapy for pediatric RSS, even without central cannulation capability. Distinguishing cardiogenic from vasoplegic phenotypes and identifying severe ARDS guided configuration selection (VA vs VV). These findings highlight the feasibility of peripheral ECMO in carefully selected patients within resource-limited settings, achieving survival comparable to international reports.
背景:难治性脓毒性休克(RSS)在儿童中具有很高的死亡率,尽管在重症监护方面取得了进展。体外膜氧合(ECMO)是常规治疗失败时的一种抢救治疗方法。来自拉丁美洲的证据仍然有限,没有来自智利的详细报告。方法:我们在智利儿科ICU进行了一项回顾性单中心研究(2009-2024)。年龄1个月至17岁的感染性休克患者对最大常规治疗无反应。我们分析了人口统计学、疾病严重程度、ECMO模式、并发症和结果。主要终点是生存至出院。结果:9例患者接受ECMO(中位年龄6.3岁)。所有患者均有RSS,常伴有严重的ARDS。构型包括静脉动脉(VA, n = 4)、静脉静脉(VV, n = 4)和静脉动静脉(VAV, n = 1),均通过外周插管。ECMO前血管活性-肌力评分中位数为117,其中78%在ECMO期间需要肾脏替代治疗。总生存率为55%(5/9)。幸存者的ECMO运行时间较长(中位11天对3天),ICU住院时间较长(中位63天对5天)。出血是最常见的并发症(颅内n = 3,胃肠道n = 1)。一名幸存者患上偏瘫;随访1年未见认知障碍。结论:即使没有中心插管能力,ECMO也可以作为儿童RSS的有效抢救治疗。区分心源性和血管截瘫表型并识别严重ARDS引导构型选择(VA vs VV)。这些发现强调了在资源有限的情况下,在精心选择的患者中进行外周ECMO的可行性,实现了与国际报道相当的生存率。
{"title":"Extracorporeal membrane oxygenation in pediatric septic shock: A single-center experience in Chile.","authors":"Loreto Godoy, Mauricio Yunge, Jorge Rufs, Alejandra Gatica, Carlos Muñoz, Cristian Valverde","doi":"10.1177/03913988251409039","DOIUrl":"10.1177/03913988251409039","url":null,"abstract":"<p><strong>Background: </strong>Refractory septic shock (RSS) in children carries high mortality despite advances in critical care. Extracorporeal membrane oxygenation (ECMO) is a rescue therapy when conventional management fails. Evidence from Latin America remains limited, with no detailed reports from Chile.</p><p><strong>Methods: </strong>We conducted a retrospective single-center study (2009-2024) in a Chilean Pediatric ICU. Patients aged 1 month to 17 years with septic shock unresponsive to maximal conventional therapy were included. We analyzed demographics, illness severity, ECMO modality, complications, and outcomes. Primary endpoint was survival to hospital discharge.</p><p><strong>Results: </strong>Nine patients received ECMO (median age = 6.3 years). All had RSS, frequently associated with severe ARDS. Configurations included venoarterial (VA; <i>n</i> = 4), venovenous (VV; <i>n</i> = 4), and venoarteriovenous (VAV; <i>n</i> = 1), all via peripheral cannulation. Pre-ECMO median vasoactive-inotropic score was 117, and 78% required renal replacement therapy during ECMO. Overall survival was 55% (5/9). Survivors had longer ECMO runs (median 11 days vs 3 days) and ICU stays (median 63 days vs 5 days). Hemorrhage was the most frequent complication (intracranial <i>n</i> = 3; gastrointestinal <i>n</i> = 1). One survivor developed hemiparesis; no cognitive impairment was observed at 1-year follow-up.</p><p><strong>Conclusions: </strong>ECMO can be an effective rescue therapy for pediatric RSS, even without central cannulation capability. Distinguishing cardiogenic from vasoplegic phenotypes and identifying severe ARDS guided configuration selection (VA vs VV). These findings highlight the feasibility of peripheral ECMO in carefully selected patients within resource-limited settings, achieving survival comparable to international reports.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"17-22"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-12-14DOI: 10.1177/03913988251398850
Natasha D Lopez, Christina Jacob, Tia N Bullard
Background: Achieving adequate sedation on extracorporeal membrane oxygenation (ECMO) is challenging due to altered pharmacokinetics. Limited data exists on phenobarbital in adult ECMO patients. The aim was to characterize the volume of distribution (Vd) and dosing.
Methods: This single-center retrospective study examined adult ECMO patients who received intravenous phenobarbital and corresponding serum concentrations between January 1, 2017 and March 1, 2024. Phenobarbital levels for analysis were obtained 0.5-4 h after phenobarbital loading dose (LD) and up to 4 h prior to a maintenance dose; this time frame was adjusted to 0.5-1 h if on continuous venovenous hemofiltration (CVVH).
Results: Sixteen venovenous ECMO patients with 18 LD and 70 phenobarbital concentrations were evaluated. The median LD was 1225 mg (796.3-1437.8); 15 mg/kg (8.8-16.2) total body weight (TBW). The median total Vd was 67.7 L (46.8-80.8), 0.94 L/kg (0.72-1.22) ideal body weight (IBW), and 0.71 L/kg (0.67-0.82) TBW. Weight-based LD and concentration demonstrated a stronger correlation for TBW (r = 0.93, p < 0.001) versus IBW (r = 0.64, p = 0.003). Comparing BMI <30 and BMI ⩾30 kg/m2 patients there was a difference in total Vd (p = 0.02) and IBW-normalized Vd (p = 0.006), but no difference in TBW-normalized Vd (p = 0.31). The median maintenance dose was 2.4 mg/kg/day (1.7-2.7) TBW; CVVH patients required 11.7 mg/kg/day TBW. Phenobarbital concentration change was <3% after ECMO decannulation.
Conclusion: In adult ECMO patients, phenobarbital's Vd normalized to TBW, was consistent with critically ill non-ECMO patients. Obesity affected Vd, CVVH influenced maintenance dosing, but ECMO decannulation did not impact phenobarbital concentrations.
{"title":"Characterization of phenobarbital pharmacokinetics and dosing in adults receiving extracorporeal membrane oxygenation.","authors":"Natasha D Lopez, Christina Jacob, Tia N Bullard","doi":"10.1177/03913988251398850","DOIUrl":"10.1177/03913988251398850","url":null,"abstract":"<p><strong>Background: </strong>Achieving adequate sedation on extracorporeal membrane oxygenation (ECMO) is challenging due to altered pharmacokinetics. Limited data exists on phenobarbital in adult ECMO patients. The aim was to characterize the volume of distribution (Vd) and dosing.</p><p><strong>Methods: </strong>This single-center retrospective study examined adult ECMO patients who received intravenous phenobarbital and corresponding serum concentrations between January 1, 2017 and March 1, 2024. Phenobarbital levels for analysis were obtained 0.5-4 h after phenobarbital loading dose (LD) and up to 4 h prior to a maintenance dose; this time frame was adjusted to 0.5-1 h if on continuous venovenous hemofiltration (CVVH).</p><p><strong>Results: </strong>Sixteen venovenous ECMO patients with 18 LD and 70 phenobarbital concentrations were evaluated. The median LD was 1225 mg (796.3-1437.8); 15 mg/kg (8.8-16.2) total body weight (TBW). The median total Vd was 67.7 L (46.8-80.8), 0.94 L/kg (0.72-1.22) ideal body weight (IBW), and 0.71 L/kg (0.67-0.82) TBW. Weight-based LD and concentration demonstrated a stronger correlation for TBW (<i>r</i> = 0.93, <i>p</i> < 0.001) versus IBW (<i>r</i> = 0.64, <i>p</i> = 0.003). Comparing BMI <30 and BMI ⩾30 kg/m<sup>2</sup> patients there was a difference in total Vd (<i>p</i> = 0.02) and IBW-normalized Vd (<i>p</i> = 0.006), but no difference in TBW-normalized Vd (<i>p</i> = 0.31). The median maintenance dose was 2.4 mg/kg/day (1.7-2.7) TBW; CVVH patients required 11.7 mg/kg/day TBW. Phenobarbital concentration change was <3% after ECMO decannulation.</p><p><strong>Conclusion: </strong>In adult ECMO patients, phenobarbital's Vd normalized to TBW, was consistent with critically ill non-ECMO patients. Obesity affected Vd, CVVH influenced maintenance dosing, but ECMO decannulation did not impact phenobarbital concentrations.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"23-29"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}